TARGETED THERAPIES Importance of patient selection for EGFR TKIs in lung cancer

Journal article

Open access

Peer reviewed

Ariel Lopez-Chavez and Giuseppe Giaccone

Nature reviews. Clinical oncology, v 7(7), pp 360-362

01 Jul 2010

PMID: 20592709

Files and links (1)

url

https://www.ncbi.nlm.nih.gov/pmc/articles/7020688View

Open

Life Sciences & Biomedicine

Oncology

Science & Technology

3 Record Views

8 citations in Scopus

Title: TARGETED THERAPIES Importance of patient selection for EGFR TKIs in lung cancer
Creators: Ariel Lopez-Chavez - National Cancer Institute
Giuseppe Giaccone - National Institutes of Health
Publication Details: Nature reviews. Clinical oncology, v 7(7), pp 360-362
Publisher: Springer Nature
Number of pages: 4
Grant note: ZIABC011269 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) Z01 BC010548; Z01 BC010453-07 / Intramural NIH HHS; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
Resource Type: Journal article
Language: English
Academic Unit: General Internal Medicine
Web of Science ID: WOS:000279390800002
Scopus ID: 2-s2.0-77954223426
Other Identifier: 991022059862904721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool: